Epidemiological factors in patients with larynx cancer treated by surgery, radiotherapy or therapeutic associations

Laryngeal cancer continues to be the most widespread tumors of the head and neck regions [1,2]. Despite the signifi cant advancements in the care of laryngeal cancer patients during the last several decades, therapeutic complications and the increased attention to quality of life have led to the need to carry out further studies on this population [3]. In addition to laryngeal malignity itself, factors related to acute and late or chronic treatment, secondary primary cancers, intercurrent disease and psychosocial factors are responsible from patient morbidity and mortality. Loss of the protective function of the nose and upper respiratory tracts resulting from the total laryngectomy operation due to larynx cancer make these cases more sensitive to lung infections in comparison with normal

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Epidemiological factors in patients with larynx cancer treated by surgery, radiotherapy or therapeutic associations

Abstract: Citation: Nunes Da Silva GHB, Miranda MG, Rodrigues DS, De Souza GR, Ribeiro CV (2019) Epidemiological factors in patients with larynx cancer treated by surgery, radiotherapy or therapeutic associations. Arch Otolaryngol Rhinol 5(2): 043-049.

Cited by 2 publications

References 8 publications

Machine learning in personalized laryngeal cancer management: insights into clinical characteristics, therapeutic options, and survival predictions

Machine learning in personalized laryngeal cancer management: insights into clinical characteristics, therapeutic options, and survival predictions

Respiratory system pathologies in patients who underwent total laryngectomy due to larynx cancer

Contact Info

Product

Resources

About